In conclusion, this study explored the plasma concentration of six neuropeptides, including α-MSH, β-Endorphin, Neurotensin, Orexin-A, Oxytocin, and Substance P in FES, BD, and MDD, and tested their differentiating potential to distinguish patients from controls. This evidence concerns the gene TAC1 and major depressive disorder.